Fidaxomicin and OP-1118 inhibit C. difficile toxin A- and B-mediated inflammatory responses via inhibition of NF-κB activity.
about
Fidaxomicin and OP-1118 inhibit C. difficile toxin A- and B-mediated inflammatory responses via inhibition of NF-κB activity.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Fidaxomicin and OP-1118 inhibi ...... inhibition of NF-κB activity.
@en
Fidaxomicin and OP-1118 inhibi ...... inhibition of NF-κB activity.
@nl
type
label
Fidaxomicin and OP-1118 inhibi ...... inhibition of NF-κB activity.
@en
Fidaxomicin and OP-1118 inhibi ...... inhibition of NF-κB activity.
@nl
prefLabel
Fidaxomicin and OP-1118 inhibi ...... inhibition of NF-κB activity.
@en
Fidaxomicin and OP-1118 inhibi ...... inhibition of NF-κB activity.
@nl
P2093
P2860
P356
P1476
Fidaxomicin and OP-1118 inhibi ...... inhibition of NF-κB activity.
@en
P2093
Caroline C Mussatto
Charalabos Pothoulakis
Christina Ortiz
Ciaran P Kelly
Diana Hoang-Ngoc Tran
Elaine C Lee
Hon Wai Koon
Xinhua Chen
P2860
P356
10.1128/AAC.01513-17
P407
P50
P577
2017-12-21T00:00:00Z